These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21888900)

  • 1. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.
    Hamdouch K; Rodríguez C; Pérez-Venegas J; Rodríguez I; Astola A; Ortiz M; Yen TJ; Bennani M; Valdivia MM
    Clin Chim Acta; 2011 Nov; 412(23-24):2267-71. PubMed ID: 21888900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics characterization of CENP-B epitope in Moroccan scleroderma patients with anti-centromere autoantibodies.
    Zian Z; Bennani Mechita M; Hamdouch K; Maamar M; Barakat A; Ghailani Nourouti N; El Aouad R; Valdivia MM; Arji N
    Immunol Lett; 2020 May; 221():1-5. PubMed ID: 32057908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
    Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
    J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in systemic sclerosis.
    Vázquez-Abad D; Rothfield NF
    Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization of heterochromatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma.
    Furuta K; Hildebrandt B; Matsuoka S; Kiyosawa K; Reimer G; Luderschmidt C; Chan EK; Tan EM
    J Mol Med (Berl); 1998 Jan; 76(1):54-60. PubMed ID: 9462868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-reactive idiotype in scleroderma.
    Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
    Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-kinetochore directed autoantibodies in scleroderma/CREST. Identification of an activity recognizing a metaphase chromosome core non-histone protein.
    Jeppesen P; Nicol L
    Mol Biol Med; 1986 Aug; 3(4):369-84. PubMed ID: 3095608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens.
    Whyte J; Hough D; Maddison PJ; McHugh NJ
    J Autoimmun; 1994 Jun; 7(3):413-24. PubMed ID: 7522457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen.
    Fregeau DR; Leung PS; Coppel RL; McNeilage LJ; Medsger TA; Gershwin ME
    Arthritis Rheum; 1988 Mar; 31(3):386-92. PubMed ID: 3282519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
    Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
    J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
    Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
    J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.